Aromatic or modified aromatic: — Other: — Drugs: — Anti-infective agents: — Other
Part of: 293399 — Other: — Other:
N314505 · 2020-10-06 — The tariff classification of Favipiravir (CAS No. 259793-96-9) in bulk form, from Taiwan
, Ltd., you requested a tariff classification ruling. Favipiravir is a pyrazinecarboxamide derivative with activity against RNA viruses. It is an anti-viral agent that selectively and potently inhibits the RNA-dependent RNA polymerase (RdRp) of RNA viruses. Currently, Favipiravir is undergoing phase 2 clinical trials for the treatment of Covid-19 in the United States and it is also indicated for the treatment of influenza in Japan. The applicable subheading for the Favipiravir in bulk form will be 2933.99.4600, Harmonized Tariff Schedule of the United States (HTSUS), which provides for…
N251613 · 2014-04-10 — The tariff classification of Albendazole (CAS-54965-21-8), imported in bulk form, from Spain
The subject product, Albendazole, is in a class of drugs called antihelmintics. It is indicated for the treatment of parenchymal neurocysticercosis due to active lesions caused by larval forms of the pork tapeworm, Taenia solium. Albendazole is also indicated for the treatment of cystic hydatid disease of the liver, lung, and peritoneum, caused by the larval form of the dog tapeworm, Echinococcus granulosus. The applicable subheading for the Albendazole, imported in bulk form, will be 2933.99.4600, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Heterocyclic…
N011563 · 2007-05-23 — The tariff classification of Telaprevir (VX-950) (CAS- 402957-28-2), imported in both bulk and dosage forms, from Portugal
The subject product, Telaprevir, is a protease inhibitor (PI) for the treatment of hepatitis C virus (HCV) infection. You state that Vertex has initiated a Phase 2b clinical trial in the United States to evaluate sustained viral response rates in treatment-naïve patients with genotype-1 HCV. Vertex is also conducting a Phase 2b trial in patients with genotype-1 HCV who have not achieved a sustained viral response with previous interferon-based treatment. You suggest that Telaprevir in bulk is classifiable in subheading 2924.29. We respectfully disagree. In its structure, Telaprevir contains a…
K88028 · 2004-07-22 — The tariff classification of Gemifloxacin (CAS-175463-14-6) imported in bulk form, from India
The subject product, Gemifloxacin, is a synthetic, broad-spectrum, antibacterial agent. It is indicated for use as an antibacterial drug in the treatment of acute bacterial exacerbation of chronic bronchitis and community-acquired pneumonia. For the record, although Gemifloxacin is active against a wide range of gram-negative and gram-positive microorganisms, you have presented no evidence that it is closely related to any naturally occurring antibiotic. Explanatory Note 29.41, HTS. The applicable subheading for Gemifloxacin, imported in bulk form, will be 2933.99.4600, Harmonized Tariff…
R00314 · 2004-05-02 — The tariff classification of Gemifloxacin Mesylate (CAS-204519-65-3), imported in bulk form, from Korea
The subject product, Gemifloxacin Mesylate, is a synthetic, broad-spectrum, antibacterial agent. It is indicated for use as an antibacterial drug, in the treatment of acute bacterial exacerbation of chronic bronchitis and community-acquired pneumonia. For the record, although Gemifloxacin Mesylate is active against a wide range of Gram-negative and Gram-positive microorganisms, you have presented no evidence that it is closely related to any natural antibiotic. Explanatory Note 29.41, HTS. The applicable subheading for Gemifloxacin Mesylate, imported in bulk form, will be 2933.99.4600,…
Not sure this code fits your product? HaiLang AI determines the US HTS code from a description in about a minute.
Classify a product